First chronotherapeutic agent for hypertension and angina now avaliable in U.S. June 7, 1996 No Comments
Taisho researchers reveal cGMP-dependent phosphodiesterase (PDE V) inhibitors May 31, 1996 No Comments
Phase II clinical trial on Gensia's second-generation adenosine-regulating agent commence May 31, 1996 No Comments
RSS